Merck & Co Inc
F:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
F:6MK
|
US |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
|
U
|
US Bancorp
BMV:USB
|
US |
|
A
|
Advantest Corp
XBER:VAN
|
JP |
|
T
|
Trip.com Group Ltd
F:CLV
|
CN |
|
A
|
AXA SA
XBER:AXA
|
FR |
|
B
|
Barito Pacific Tbk PT
XMUN:OB8
|
ID |
|
S
|
Southern Co
XMUN:SOT
|
US |
|
N
|
News Corp
F:NC0
|
US |
|
B
|
BNP Paribas SA
XMUN:BNP
|
FR |
Wall St Price Targets
6MK Price Targets Summary
Merck & Co Inc
According to Wall Street analysts, the average 1-year price target for 6MK is 111.63 EUR with a low forecast of 85.38 EUR and a high forecast of 133.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6MK's stock price target?
Price Target
111.63
EUR
According to Wall Street analysts, the average 1-year price target for 6MK is 111.63 EUR with a low forecast of 85.38 EUR and a high forecast of 133.14 EUR.
What is the Revenue forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 2%.
What is the Net Income forecast for Merck & Co Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 8 years is 4%.
